Parallel Analyses by Mass Spectrometry (MS) and Reverse Phase Protein Array (RPPA) Reveal Complementary Proteomic...

Area of Science:

• Biochemistry and Molecular Biology
• Cancer Research
• Proteomics

Background:

• High-plex proteomic technologies are crucial for understanding complex diseases, especially cancer.
• Existing proteomic methods have limitations hindering comprehensive proteome analysis.
• Integrating multiple proteomic approaches can improve protein target coverage and discovery.

Purpose of the Study:

• To systematically assess and compare mass spectrometry (MS) and reverse phase protein array (RPPA) performance.
• To develop an integrated workflow combining MS and RPPA for enhanced proteomic discovery.
• To evaluate these technologies in triple-negative breast cancer (TNBC) samples.

Main Methods:

• Analyzed 14 fresh frozen TNBC tissue samples (tumors vs. adjacent non-cancerous) and cell lines.
• Utilized liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS) for proteomic profiling.
• Employed reverse phase protein array (RPPA) for profiling over 300 cancer-relevant proteins and phosphoproteins.

Main Results:

• Both MS and RPPA successfully differentiated sample groups, showing distinct proteomic patterns.
• Identified minimal overlap in protein targets between the two methods.
• Mechanism-based analysis revealed complementary biological insights from each technology.

Conclusions:

• MS and RPPA offer complementary strengths for proteomic analysis in cancer research.
• An integrated dual-proteomic strategy can significantly augment protein target discovery.
• This approach holds promise for advancing biomarker discovery and mechanism studies in TNBC.